Patients' Acceptability, Adherence and Satisfaction on the Modified Shorter All-oral Multidrug-resistant Tuberculosis Regimen: a Two-phase Cross-sectional Study in Tanzania

Overview

Journal BMJ Open

Specialty General Medicine

Date 2025 Mar 4

PMID 40037680

Authors

Julieth Lalashowi

Happiness Mvungi

Zawadi Mwaisango

Doreen Pamba

Athuman Mohamed

Catherine Gitige

Pendomartha Joseph Shayo

Isaac Lekule

Hamim Omary

Riziki Kisonga

Emmanuel Matechi

Stellah G Mpagama

Willyhelmina Olomi

Nyanda Elias Ntinginya

Albino Kalolo

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine patients' acceptability, satisfaction and adherence to shorter all-oral multidrug-resistant tuberculosis (MDR-TB) regimen in Tanzania.

Design: A two-phase cross-sectional study with data collected within 6 months of Removed Injectable modified Short-course regimens for EXpert MDR-TB (RISE) study implementation and the second phase within 15 months of implementation using the same reference populations.

Settings: 18 health facilities across eight regions of Tanzania.

Participants: Rifampicin-resistant TB/MDR-TB patients enrolled in the RISE study.

Outcome Measures: We assessed patients' acceptability, adherence and satisfaction with the regimen using an interval scale structured questionnaire.

Results: The majority of the patients found the shorter oral MDR-TB treatment acceptable, adhered to it well and were generally satisfied. The median score (IQR) for acceptability was 1.7 (1.03-2.00) but it ranged between 1.3 (1.3-2) and 1.7 (1-1.79) for the first and second phases, respectively. Regarding adherence, the median score (IQR) stood at 4 (3.67-4.67) with scores significantly higher in the second phase at 4.33 (4.00-5.007) compared with the first at 4.67 (4.00-5.0), p value=0.01. The overall satisfaction was high at 1.5 (1.33-1.78) but it ranged between 1.22 (1.00-1.78) and 1.42 (1.11-1.78) for the first and second phases, respectively. Worrying about side effects was statistically associated with adherence (p value<0.05). No statistically significant associations were found for acceptability and satisfaction.

Conclusion: Generally, the modified shorter oral MDR-TB regimen was accepted, and patients reported good adherence and were satisfied. More engagement with patients could provide more insights into factors that can maximise acceptability, adherence and satisfaction with the regimen.

References

Xing W, Zhang R, Jiang W, Zhang T, Pender M, Zhou J . Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China - A Mixed Method Research Study. Infect Drug Resist. 2021; 14:999-1012. PMC: 7979342. DOI: 10.2147/IDR.S293583. View

Mirzayev F, Viney K, Linh N, Gonzalez-Angulo L, Gegia M, Jaramillo E . World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2020; 57(6). PMC: 8176349. DOI: 10.1183/13993003.03300-2020. View

Law S, Daftary A, ODonnell M, Padayatchi N, Calzavara L, Menzies D . Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review. Eur Respir J. 2018; 53(1). DOI: 10.1183/13993003.01030-2018. View

Myemba D, Bwire G, Sambayi G, Maganda B, Njiro B, Ndumwa H . Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar Es Salaam region, Tanzania. JAC Antimicrob Resist. 2021; 2(4):dlaa108. PMC: 8210025. DOI: 10.1093/jacamr/dlaa108. View

Nezenega Z, Gacho Y, Tafere T . Patient satisfaction on tuberculosis treatment service and adherence to treatment in public health facilities of Sidama zone, South Ethiopia. BMC Health Serv Res. 2013; 13:110. PMC: 3658999. DOI: 10.1186/1472-6963-13-110. View

S Ingersoll K, Cohen J . The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008; 31(3):213-24. PMC: 2868342. DOI: 10.1007/s10865-007-9147-y. View

Tadesse T, Demissie M, Berhane Y, Kebede Y, Abebe M . Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study. BMC Public Health. 2013; 13:424. PMC: 3644232. DOI: 10.1186/1471-2458-13-424. View

Gugssa Boru C, Shimels T, Bilal A . Factors contributing to non-adherence with treatment among TB patients in Sodo Woreda, Gurage Zone, Southern Ethiopia: A qualitative study. J Infect Public Health. 2017; 10(5):527-533. DOI: 10.1016/j.jiph.2016.11.018. View

Maynard C, Tariq S, Sotgiu G, Migliori G, Boom M, Field N . Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis. EClinicalMedicine. 2023; 61:102057. PMC: 10338299. DOI: 10.1016/j.eclinm.2023.102057. View

10.

Almeida A, Adjuntsov M, Bushura W, Delgado E, Drasher M, Fernando-Pancho M . Hear us! Accounts of people treated with injectables for drug-resistant TB. Public Health Action. 2021; 11(3):146-154. PMC: 8455027. DOI: 10.5588/pha.21.0031. View

11.

Zhang M, Zhou L, Zhang Y, Chen B, Peng Y, Wang F . Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. Eur J Med Res. 2021; 26(1):31. PMC: 8019161. DOI: 10.1186/s40001-021-00502-0. View

12.

Jimmy B, Jose J . Patient medication adherence: measures in daily practice. Oman Med J. 2011; 26(3):155-9. PMC: 3191684. DOI: 10.5001/omj.2011.38. View

13.

Nezenega Z, Perimal-Lewis L, Maeder A . Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review. Int J Environ Res Public Health. 2020; 17(15). PMC: 7432798. DOI: 10.3390/ijerph17155626. View

14.

Karnan A, Jadhav U, Ghewade B, Ledwani A, Shivashankar P . A Comprehensive Review on Long vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT). Cureus. 2024; 16(1):e52706. PMC: 10879947. DOI: 10.7759/cureus.52706. View

15.

Dobbels F, Van Damme-Lombaert R, Vanhaecke J, de Geest S . Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant. 2005; 9(3):381-90. DOI: 10.1111/j.1399-3046.2005.00356.x. View

16.

Gebreweld F, Kifle M, Gebremicheal F, Simel L, Gezae M, Ghebreyesus S . Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018; 37(1):1. PMC: 5756387. DOI: 10.1186/s41043-017-0132-y. View

17.

Bea S, Lee H, Kim J, Jang S, Son H, Kwon J . Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients. Front Pharmacol. 2021; 12:625078. PMC: 8005597. DOI: 10.3389/fphar.2021.625078. View

18.

Farrell B, Merkley V, Ingar N . Reducing pill burden and helping with medication awareness to improve adherence. Can Pharm J (Ott). 2013; 146(5):262-9. PMC: 3785195. DOI: 10.1177/1715163513500208. View

19.

Strait A, Velasquez A, Handley M, Leong K, Najmabadi A, Powe N . Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system. Clin Kidney J. 2018; 11(4):540-548. PMC: 6070069. DOI: 10.1093/ckj/sfx141. View

20.

Tesfahuneygn G, Medhin G, Legesse M . Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes. 2015; 8:503. PMC: 4588463. DOI: 10.1186/s13104-015-1452-x. View